»ùÒò±à¼­Ð§ÀÍ

KOϸ°ûϵ

  • PBRM1»ùÒòÇóýA549ϸ°û
    »õºÅ: EDJ0001-K01
    »ùÒòÃû³Æ: PBRM1
    »ùÒòID: 55193
    ¹æ¸ñ: 1¡Á10?cells
    ϸ°ûÐÎ̬: Ìù±Ú
  • PKM1»ùÒòÇóýA549ϸ°û
    »õºÅ: EDJ0002-K02
    »ùÒòÃû³Æ: PKM1
    »ùÒòID: 5315
    ¹æ¸ñ: 1¡Á10?cells
    ϸ°ûÐÎ̬: Ìù±Ú
  • S100A9»ùÒòÇóýA549ϸ°û
    »õºÅ: EDJ0003-K03
    »ùÒòÃû³Æ: S100A9
    »ùÒòID: 6280
    ¹æ¸ñ: 1¡Á10?cells
    ϸ°ûÐÎ̬: Ìù±Ú
  • YTHDC1»ùÒòÇóýA549ϸ°û
    »õºÅ: EDJ0004-K04
    »ùÒòÃû³Æ: YTHDC1
    »ùÒòID: 91746
    ¹æ¸ñ: 1¡Á10?cells
    ϸ°ûÐÎ̬: Ìù±Ú
  • Éó²é¸ü¶à

Ò°ÉúÐÍϸ°ûϵ

¹ØÓÚÍêÃÀÕæÈË ¹ØÓÚÍêÃÀÕæÈË

ÍêÃÀÕæÈ˽¨ÉèÓÚ2017Äê8Ô£¬£¬£¬ £¬£¬£¬×øÂäÓÚ¹ãÖÝÊÐ»ÆÆÒÇø¹ú¼ÊÆóÒµ·õ»¯Æ÷£¬£¬£¬ £¬£¬£¬ÊÇÓÉÉî¸û»ùÒò±à¼­¼¼ÊõÊ®ÄêµÄ¹é¹ú²©Ê¿ÅäºÏ½¨Éè¡£¡£¡£¡£¡£¡£ÍêÃÀÕæÈËרעÓÚCRISPR/Cas»ùÒò±à¼­¼¼ÊõÑз¢¡¢Ð§Àͺ͹¤Òµ»¯¡£¡£¡£¡£¡£¡£ÍêÃÀÕæÈËÏÖÒѴËĴ󽹵㼼Êõƽ̨£ºEditx™»ùÒò±à¼­£¬£¬£¬ £¬£¬£¬Bingo™µãÍ»±ä£¬£¬£¬ £¬£¬£¬LION™Ï¸°û¶¨µã²åÈëºÍFASSTºËËá¿ìËÙ¼ì²â£¬£¬£¬ £¬£¬£¬ÎªÈ«ÇòÖÚ¶à¿ÆÑе¥Î»¼°ÆóÒµÌṩ¸ßÖÊÁ¿µÄCROЧÀÍ£¬£¬£¬ £¬£¬£¬Í¬Ê±£¬£¬£¬ £¬£¬£¬ÍêÃÀÕæÈËÒÑÐγɓÑз¢-ЧÀÍ-¹¤Òµ”µÄ±Õ»·Ä£Ê½¡£¡£¡£¡£¡£¡£ÍêÃÀÕæÈËÖÂÁ¦Óڴ×î´ó¡¢×îÈ«µÄ»ùÒò±à¼­Ð§ÀÍÆ½Ì¨£¬£¬£¬ £¬£¬£¬¿ªÕ¹»ùÒò±à¼­Ïà¹ØµÄÈ«Á´ÌõЧÀÍ£¬£¬£¬ £¬£¬£¬ÒÔ»ùÒò±à¼­¹¤Òµ“´ß»¯¼Á”µÄ½ÇÉ«£¬£¬£¬ £¬£¬£¬¼ÓËÙ»ùÒò±à¼­¹¤Òµ»¯Àú³Ì£¬£¬£¬ £¬£¬£¬Ô츣ÈËÀ࿵½¡¡£¡£¡£¡£¡£¡£

0 +

Äê»ùÒò±à¼­ÂÄÀú
ÔÚCRISPR»ùÒò±à¼­½â¾ö¼Æ»®·½ÃæÓµÓÐÊ®¶àÄêµÄÂÄÀú

0 %

¿Í»§Öª×ã¶È
CROЧÀÍÒò׿ԽµÄЧ¹ûºÍ¿É¿¿ÐÔ¶øÉîÊܿͻ§ÐÅÈÎ

0 +

»ùÒò±à¼­Ï¸°ûϵ
ÔÚ¾«×¼»ùÒò×é±à¼­·½ÃæÓµÓо«²ÊЧÂʺÍÀÖ³ÉÂÊ

¹ØÓÚÍêÃÀÕæÈË ¹ØÓÚÍêÃÀÕæÈË

EDITGENE is rooted in independent technology development and upholds the business philosophy of "Innovation ¡¤ Sharing." We focus on developing and optimizing CRISPR/Cas-based genome editing technologies. Currently, we have established four core technology platforms: Editx?, Bingo?, HES?, and FASST, providing cell gene editing and CRISPR detection CRO services to research institutions and pharmaceutical companies worldwide.

0 +

Years of Expertise
A decade of innovation in gene editing solutions.

0 %

Client Satisfaction
Trusted by clients for exceptional results and reliability.

0 +

Successfully Edited Cell Lines
Demonstrating a robust track record in precision genome editing.

¹«Ë¾Ê¹Ãü
Enable the widespread adoption of gene editing technologies
Enable the widespread adoption of gene editing technologies
Expand and enhance applications for genome editing across diverse fields.
Expand and enhance applications for genome editing across diverse fields.
Reduce the cost of gene edit-ing
Reduce the cost of gene editing, make it accessible for broader research and therapeutic uses.

רҵÍŶÓ

ÏàÖúͬ°é

Roche
Merck
ÈüĬ·É
BioTrader,Inc
SATT NORD
University of California, San Francisco
Memorial Sloan Kettering Cancer Center
Cleveland clinic
Jnvena
Texas A&M University School of Dentistry
EVERGREEN
IRBM S.p.A.
Max Planck Institute for Multidisciplinary Sciences
Sibylla Biotech SpA
Technion - Israel Institute of Technology
University of the Basque Country
Utah University
Uppsala universitet
Öйú¿ÆÑ§ÔºÉîÛÚÀí¹¤´óѧ
±±¾©Ö×ÁöÒ½Ôº
ÄϾ©´óѧ
ÉîÛÚÍåʵÑéÊÒ
ÖÐɽ´óѧÁ¥ÊôµÚÒ»Ò½Ôº
ÖÐɽ´óѧÖ×Áö·ÀÖÎÖÐÐÄ
ÅÉÕæÉúÎï
¹Ì°²²©½¡ÉúÎï¼¼ÊõÓÐÏÞ¹«Ë¾
¹ãÖݶ«ÔóÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾
ÖØÇìÀ³²©Ë¹ÉúÎï¼¼ÊõÓÐÏÞ¹«Ë¾
±±¾©ÂѰ×ÖÊ×éÑо¿ÖÐÐÄ
OIP-C
ͼάÉúÎï
RBM
ÆÕÈüî£
ÉîÛÚ°¬É­ÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾
΢½÷ÉúÎï
ά̩È𡣡£¡£¡£¡£¡£¨ÉϺ££©ÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾
°ÄÃÅ´óѧ
±±¾©»¯¹¤´óѧ
¸´µ©´óѧÁ¥ÊôÖ×ÁöÒ½Ôº
¸´µ©´óѧÉúÃü¿ÆÑ§Ñ§Ôº
¹þ¶û±õÒ½¿Æ´óѧ
»ªÄÏũҵ´óѧ¶¯Îï¿ÆÑ§Ñ§Ôº
»ªÖпƼ¼´óѧ
¼ªÁÖ´óѧ¶¯Îï¿ÆÑ§Ñ§Ôº
¾üÊÂҽѧÑо¿Ôº
ÄÏͨ´óѧ
ɽ¶«Ê¡µÚÒ»Ò½¿Æ´óѧ
ɽ¶«Ê¡Á¢Ò½Ôº
ÉϺ£½»Í¨´óѧҽѧԺ
ÉϺ£½»Í¨´óѧҽѧԺÁ¥ÊôµÚ¾ÅÈËÃñÒ½Ôº
ÉϺ£½»Í¨´óѧҽѧԺÁ¥ÊôÈð½ðÒ½Ôº
ÉϺ£ÊÐͬ¼ÃÒ½Ôº
ÉϺ£ÖÐÒ½Ò©´óѧ
Î÷±±´óѧ
Ïû»¯µÀ¶ñÐÔÖ×Áö½ÌÓý²¿ÖصãʵÑéÊÒ
н®µÚ¶þҽѧԺ»ù´¡Ò½Ñ§Ôº
Õã½­´óѧ
Öйú¿ÆÑ§¼¼Êõ´óѧ(K)
ÖйúÈËÃñ½â·Å¾üˮʦ¾üÒ½´óѧˮʦҽѧϵ¸ßÎÂʵÑéÊÒ
ÖйúÒ©¿Æ´óѧ
Öйúҽѧ¿ÆÑ§Ôº»ù´¡Ò½Ñ§Ñо¿
Öйúҽѧ¿ÆÑ§ÔºÒ½Ò©ÉúÎï¼¼ÊõÑо¿Ëù
ÖÐɽ´óѧ
ÖÐɽ´óѧÁ¥ÊôµÚÈýÒ½Ôº
×ñÒåÒ½¿Æ´óѧ
Technion_official_seal

¿Í»§ÆÀ¼Û

±±¾©»ªÈð°îÑÐÉúËù
¸ðÏÈÉú

±±¾©»ªÈð°îÑÐÉúËù

±±¾©»ªÈð°îÑÐÉúËù ±±¾©»ªÈð°îÑÐÉúËù ±±¾©»ªÈð°îÑÐÉúËù ±±¾©»ªÈð°îÑÐÉúËù ±±¾©»ªÈð°îÑÐÉúËù

ÏÖÔÚºÍÍêÃÀÕæÈËÏàÖúÖ÷Òª×öCRISPR»ùÒò±à¼­µÄϸ°û¡£¡£¡£¡£¡£¡£º£ÄÚÒ²ÓÐһЩÆäËû×ö»ùÒò±à¼­Ï¸°ûµÄÆóÒµ£¬£¬£¬ £¬£¬£¬µ«ÏñÍêÃÀÕæÈËÕâÑùµÄCRISPR¼¼ÊõÃÅ»§»¹½ÏÁ¿ÉÙ£¬£¬£¬ £¬£¬£¬²¢ÇÒÒ²½ÏÁ¿×¼£¬£¬£¬ £¬£¬£¬ÀÖ³ÉÂʽÏÁ¿¸ß¡£¡£¡£¡£¡£¡£Ã¿¸ö½ÚµãµÄÖÊÁ¿¼ì²âºÍ»ã±¨¶¼½ÏÁ¿×¨Òµ£¬£¬£¬ £¬£¬£¬Êý¾Ý½»¸¶µÄЧ¹ûÒ²½ÏÁ¿ºÃ£¬£¬£¬ £¬£¬£¬·´ÏìÒ²½ÏÁ¿ÊµÊ±£¬£¬£¬ £¬£¬£¬ÄÜÈÿͻ§Öª×ã¡£¡£¡£¡£¡£¡£


²úÆ·»òЧÀÍ: CRISPR»ùÒò±à¼­
ÎÂÊϼ¯ÍÅ
ÔøÏÈÉú

ÎÂÊϼ¯ÍÅ

ÎÂÊϼ¯ÍÅ ÎÂÊϼ¯ÍÅ ÎÂÊϼ¯ÍÅ ÎÂÊϼ¯ÍÅ ÎÂÊϼ¯ÍÅ

ÍêÃÀÕæÈ˵ÄCRISPR¼ì²âЧ¹û»¹¿ÉÒÔ£¬£¬£¬ £¬£¬£¬ºãÎÂÀ©Ôö+CRISPR£¬£¬£¬ £¬£¬£¬½ÏÁ¿¼òÆÓÀû±ã£¬£¬£¬ £¬£¬£¬Ê±¼äÉÏÓÐÓÅÊÆ¡£¡£¡£¡£¡£¡£¹ØÓÚÍêÃÀÕæÈ˵ÄÖíÎÁ¼ì²â²úÆ·£¬£¬£¬ £¬£¬£¬½ÓÏÂÀ´»áÀ©´óÑùÆ·Á¿£¬£¬£¬ £¬£¬£¬¼ÌÐøÆÀ¼Û¡£¡£¡£¡£¡£¡£


²úÆ·»òЧÀÍ: CRISPR¼ì²â
ÉϺ£½»Í¨´óѧ
ÒóÏÈÉú

ÉϺ£½»Í¨´óѧ

ÉϺ£½»Í¨´óѧ ÉϺ£½»Í¨´óѧ ÉϺ£½»Í¨´óѧ ÉϺ£½»Í¨´óѧ ÉϺ£½»Í¨´óѧ

ÏÖÔÚÕýÔÚÊÔÓÃÍêÃÀÕæÈ˵Äcasø£¬£¬£¬ £¬£¬£¬Ð§¹û»¹ÂùºÃµÄ¡£¡£¡£¡£¡£¡£Ö®Ç°Ò²ÊÔ¹ýÊг¡ÉÏÆäËûµÄcasø£¬£¬£¬ £¬£¬£¬¿ÉÊǽÏÁ¿ÏÂÀ´ÍêÃÀÕæÈ˵ÄÐÔÄܲ»´í¡£¡£¡£¡£¡£¡£Êг¡ÉÏcasø¾ÍÊÇÃÀ¹úNEB£¬£¬£¬ £¬£¬£¬Ò»¼ÒÖ÷Òª×öÉúÎïÖÆ¼ÁµÄÆóÒµ¡£¡£¡£¡£¡£¡£ÍêÃÀÕæÈËcasø¼ì²â³öÀ´µÄÇиîЧÂʸü¸ß£¬£¬£¬ £¬£¬£¬Çиîʱ¼ä¸ü¶Ì¡£¡£¡£¡£¡£¡£


²úÆ·»òЧÀÍ: casø¼ì²â
·ðɽ´óѧ
ÁõÏÈÉú

·ðɽ´óѧ

·ðɽ´óѧ ·ðɽ´óѧ ·ðɽ´óѧ ·ðɽ´óѧ ·ðɽ´óѧ

Ö÷ÒªÓõ½Á˹ý±í´ïºÍ»ùÒòÇóýµÄϸ°û£¬£¬£¬ £¬£¬£¬ÏÖÔÚÍêÃÀÕæÈËÒѾ­Ð§ÀÍÁË2´Î£¬£¬£¬ £¬£¬£¬×öµÃͦ¿ì£¬£¬£¬ £¬£¬£¬Ð§¹û²»´í¡£¡£¡£¡£¡£¡£ºóÐøÓÐÏîÄ¿»¹»á¼ÌÐøÏàÖú¡£¡£¡£¡£¡£¡£


²úÆ·»òЧÀÍ: CRISPR»ùÒò±à¼­

ÓªÒµÁýÕÖÈ«Çò

ÏàÖú°¸Àý

0+

ÏàÖú°¸Àý
ÏàÖúͬ°é

0+

ÏàÖúͬ°é
Éæ¼°È«ÇòÓªÒµ

0+

Éæ¼°È«ÇòÓªÒµ
loading business map...

Ïà¹ØÎÄÏ×

Total Articles
Cumulative Impact Factor
Number of Users
¾«Ñ¡ÎÄÕ ÆÚ¿¯ Ó°ÏìÒò×Ó Ê¹ÓòúÆ·/ЧÀÍ ÏàÖúµ¥Î» Á´½Ó
PAIT effect: Padlock activator inhibits the trans-cleavage activity of CRISPR/Cas12a
Biosensors and Bioelectronics
10.7
PAIT effect: Padlock activator inhibits the trans-cleavage activity of CRISPR/Cas12a
Generation of recombinant antibodies by mammalian expression system for detecting S-metolachlor in
Journal of Hazardous Materials
12.2
Generation of recombinant antibodies by mammalian expression system for  detecting S-metolachlor in environmental waters
Bioactive polysaccharides from Vigna umbellata and its characterization
Biosensors and Bioelectronics
10.7
HCT116 and RAW264.7 Cell Line
Bioactive polysaccharides from Vigna umbellata and its characterization
Deep whole-genome analysis of 494 hepatocellular carcinomas
nature
50.5
PPP1R12B, KCNJ12, FGA point mutation hepg2 cell line
Deep whole-genome analysis of 494  hepatocellular carcinomas
Electrical stimulation of piezoelectric BaTiO3 coated Ti6Al4V scaffolds promotes anti-inflammatory p
Biomaterials
12.8
RAW264.7 cell line
Electrical stimulation of piezoelectric BaTiO3 coated Ti6Al4V scaffolds promotes anti-inflammatory polarization of macrophages and bone repair via MAPK/JNK inhibition and OXPHOS activation
Optimization of CRISPR/Cas12a detection assay and its application in the detection of Echinococcus g
Veterinary Parasitology
2
Optimization of CRISPR/Cas12a detection assay and its application in the detection of Echinococcus granulosus
Rapid and Simple Detection of Burkholderia gladioli in Food Matrices Using RPA-CRISPR/Cas12a Method
Foods
4.7
Rapid and Simple Detection of Burkholderia gladioli in Food Matrices Using RPA-CRISPR/Cas12a Method
Foods
4.7
Advanced Science
15.1
PAIT effect: Padlock activator inhibits the trans-cleavage activity of CRISPR/Cas12a
Biosensors and Bioelectronics
10.7
PAIT effect: Padlock activator inhibits the trans-cleavage activity of CRISPR/Cas12a
Dumbbell probe initiated multi-rolling circle amplification assisted CRISPR/Cas12a for highly sensit
Biosensors and Bioelectronics
10.7
Dumbbell probe initiated multi-rolling circle amplification assisted CRISPR/Cas12a for highly sensitive detection of clinical microRNA
A super convenient and specific CRISPR/Cas12a diagnostic platform for toxigenic Burkholderia gladiol
Food Control
5.6
A super convenient and specific CRISPR/Cas12a diagnostic platform for toxigenic Burkholderia gladioli based on virulence genes
ÁªÏµÍêÃÀÕæÈË
*
*
*
*
web logo
Kathy
ÓÊÏä: market@edgene.cn
µç»°:18102225074(΢ÐÅͬºÅ)
? service online
  • You can send email to contact us.
    ÓÊÏä
  • You can send email to contact us.
    µç»°
    ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾ÁªÏµµç»°
    Öйú×ܲ¿
    18102225074(΢ÐÅͬºÅ)

  • ÁôÑÔ
  • This is Edgene's wechat.
    ΢ÐÅ
    ÍêÃÀÕæÈËÆóҵ΢ÐŶþάÂë

  •  »Øµ½¶¥²¿